2022 - Research.com Medicine in Austria Leader Award
2017 - Member of Academia Europaea
His primary areas of investigation include Internal medicine, Endocrinology, Cholestasis, Bile acid and Ursodeoxycholic acid. His Internal medicine research includes themes of Gastroenterology and Surgery. Michael Trauner has researched Endocrinology in several fields, including Fibrosis, Bile duct and Fatty liver.
His work deals with themes such as Progressive familial intrahepatic cholestasis, Transporter, Biliary tract, Primary biliary cirrhosis and Multidrug resistance-associated protein 2, which intersect with Cholestasis. His biological study spans a wide range of topics, including Farnesoid X receptor and Pharmacology. His Ursodeoxycholic acid research is multidisciplinary, incorporating elements of Deoxycholic acid, 7α-Hydroxy-4-cholesten-3-one, Glutathione, Lithocholic acid and Alanine transaminase.
Michael Trauner mainly focuses on Internal medicine, Gastroenterology, Endocrinology, Cirrhosis and Cholestasis. His research in Liver disease, Portal hypertension, Bile acid, Fibrosis and Ursodeoxycholic acid are components of Internal medicine. His studies in Gastroenterology integrate themes in fields like Hepatocellular carcinoma, Liver transplantation and Primary sclerosing cholangitis.
His work in Endocrinology tackles topics such as Nuclear receptor which are related to areas like Receptor. His study looks at the relationship between Cirrhosis and topics such as Fatty liver, which overlap with Steatosis. The concepts of his Cholestasis study are interwoven with issues in Transporter, Bile Salt Export Pump, Primary biliary cirrhosis, Liver injury and Bile duct.
His scientific interests lie mostly in Internal medicine, Gastroenterology, Cirrhosis, Portal hypertension and Liver disease. His biological study deals with issues like Endocrinology, which deal with fields such as Monoacylglycerol lipase. His Gastroenterology study incorporates themes from Hepatocellular carcinoma, Decompensation, Cohort and Risk factor.
His research on Cirrhosis also deals with topics like
Michael Trauner focuses on Internal medicine, Gastroenterology, Cirrhosis, Liver disease and Portal hypertension. Michael Trauner focuses mostly in the field of Internal medicine, narrowing it down to matters related to Endocrinology and, in some cases, Inflammation. His Gastroenterology research incorporates elements of Odds ratio, Decompensation, Liver transplantation, Hazard ratio and Cohort.
The study incorporates disciplines such as Hepatitis C, Surgery and Risk factor in addition to Cirrhosis. In the subject of general Portal hypertension, his work in Portal venous pressure is often linked to Riociguat, thereby combining diverse domains of study. His work carried out in the field of Cholestasis brings together such families of science as Primary sclerosing cholangitis and ABCB4.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevalence of flat lesions in a large screening population and their role in colonoscopy quality improvement.
K. Reinhart;C. Bannert;D. Dunkler;P. Salzl.
Endoscopy (2013)
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
Ulrich Beuers;Kirsten M. Boberg;Roger W. Chapman;Olivier Chazouillères.
Journal of Hepatology (2009)
Bile Salt Transporters: Molecular Characterization, Function, and Regulation
Michael Trauner;James L. Boyer.
Physiological Reviews (2003)
Molecular Pathogenesis of Cholestasis
Michael Trauner;Peter J. Meier;James L. Boyer.
(2012)
Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
Katrin Panzitt;Marisa M.O. Tschernatsch;Christian Guelly;Tarek Moustafa.
Gastroenterology (2007)
The interaction of hepatic lipid and glucose metabolism in liver diseases
Lars P. Bechmann;Rebekka A. Hannivoort;Guido Gerken;Goekhan S. Hotamisligil.
Journal of Hepatology (2012)
A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis
F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser.
The New England Journal of Medicine (2016)
The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis
Michael Trauner;Marco Arrese;Carol J. Soroka;Meenakshisundaram Ananthanarayanan.
Gastroenterology (1997)
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
Guenter Haemmerle;Tarek Moustafa;Gerald Woelkart;Sabrina Büttner.
Nature Medicine (2011)
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales;Vincenzo Cardinale;Guido Carpino;Marco Marzioni.
Nature Reviews Gastroenterology & Hepatology (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Medical University of Vienna
Medical University of Vienna
University of California, San Diego
RWTH Aachen University
Newcastle University
Yale University
University of Amsterdam
University Health Network
Inova Health System
Chinese University of Hong Kong
Facebook (United States)
University of Tokyo
Chinese Academy of Sciences
Vrije Universiteit Brussel
Clemson University
Institut Pasteur
University of Southern California
University of Pennsylvania
Instituto Politécnico Nacional
University of L'Aquila
Fraunhofer Society
Indiana University – Purdue University Indianapolis
University of Bern
University of California, San Diego
University of California, Los Angeles
Carnegie Mellon University